You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Medullary Thyroid Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Detailed Look At What Patients Experience In Medullary Thyroid

Not yet recruiting
  • Medullary Thyroid Cancer
    • San Francisco, California
      Power Life Sciences
    Oct 6, 2023

    Familial Non-medullary Thyroid Cancer

    Recruiting
    • Non-Medullary Thyroid Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • Cordoba, Spain
      • +1 more
      Jan 11, 2023

      Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • +3 more
      • Groningen, Netherlands
        University Medical Centre Groningen
      Sep 8, 2022

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

      Not yet recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +3 more
      • Chang chun, Jilin, China
        Jinlin Province Cancer Hosipital
      Dec 21, 2022

      Radioactive Iodine on the Immune System in Thyroid Cancer

      Not yet recruiting
      • Thyroid Carcinoma, Nonmedullary
      • Blood drawing
      • Nijmegen, Netherlands
        Radboud University Medical Center
      Aug 13, 2023

      Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

      Recruiting
      • Metastatic Medullary Thyroid Cancer
      • single dose of CART-GFRa4 cells
      • +2 more
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Sep 16, 2022

      Children and Adults With Medullary Thyroid Cancer

      Recruiting
      • Medullary Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 7, 2022

        Thyroid Cancer Trial in New Haven, Boston (Regorafenib)

        Recruiting
        • Thyroid Cancer
        • New Haven, Connecticut
        • +1 more
        Feb 18, 2022

        Medullary Thyroid Cancer Trial (Ponatinib)

        Withdrawn
        • Medullary Thyroid Cancer
        • (no location specified)
        Oct 6, 2021

        Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

        Active, not recruiting
        Has Results
        • Solid Tumor
        • Medullary Thyroid Cancer
        • Guangzhou, Guangdong, China
        • +12 more
        May 9, 2022

        Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

        Recruiting
        • Medullary Thyroid Cancer
        • Anlotinib Hydrochloride Capsule
        • Hefei, Anhui, China
        • +18 more
        Apr 14, 2023

        Metastatic Sporadic Medullary Thyroid Cancer Patients and

        Completed
        • Metastatic Sporadic Medullary Thyroid Cancer
          • Milano, Italy
            Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
          Sep 29, 2021

          Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)

          Active, not recruiting
          • Medullary Thyroid Cancer
          • Cabozantinib (XL184) 140 mg
          • +3 more
          • St. Leonards, New South Wales, Australia
          • +49 more
          Jan 23, 2023

          Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

          Not yet recruiting
          • Non-Medullary Thyroid Carcinoma
          • Digoxin tablet
          • (no location specified)
          Aug 20, 2022

          Surgical Management of Advanced Thyroid Cancer

          Recruiting
          • Thyroid Carcinoma
          • +6 more
          • Thyroidectomy with or without lymphadenectomy or multivisceral resection
          • Rome, Italy
            Fondazione Policlinico Universitario Agostino Gemelli IRCCS
          Mar 31, 2023

          Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

          Recruiting
          • Thyroid Cancer, Medullary
          • +3 more
          • Basel, Switzerland
            University Hospital Basel, Clinic for radiology and nuclear medi
          May 23, 2022

          Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

          Recruiting
          • Malignant Thyroid Gland Neoplasm
          • +6 more
          • Quality-of-Life Assessment
          • +3 more
          • Ann Arbor, Michigan
          • +1 more
          Jan 24, 2023

          Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

          Not yet recruiting
          • Adrenal Cortical Carcinoma
          • +3 more
          • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
          • Shanghai, Shanghai, China
            Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
          Nov 19, 2023

          Thyroid Cancer Trial in United States (radiation, device, drug, other)

          Completed
          • Thyroid Cancer
          • IMRT
          • +3 more
          • Basking Ridge, New Jersey
          • +5 more
          Nov 5, 2021

          NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

          Recruiting
          • Non-Small Cell Lung Cancer
          • +2 more
          • Shanghai, Shanghai, China
          • +1 more
          Mar 17, 2022

          Medullary Thyroid Cancer (MTC) Trial run by the NCI (Pembrolizumab)

          Completed
          Has Results
          • Medullary Thyroid Cancer (MTC)
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 22, 2021

          Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal

          Not yet recruiting
          • Amyloid
          • +3 more
            • (no location specified)
            Feb 15, 2021

            Medullary Thyroid Cancer Trial in France (18F-DOPA)

            Completed
            • Medullary Thyroid Cancer
            • 18F-DOPA
            • Bordeaux, France
            • +4 more
            Mar 5, 2021

            Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

            Recruiting
            • Thyroid Cancer, Nonmedullary
            • Colon Carcinoma
            • no intervention will take place
            • Nijmegen, Gelderland, Netherlands
              RadboudUMC
            Sep 21, 2022